Evaluation of dosimetric impact of inter-application and intra-application variations in fractionated high-dose-rate intra-cavitary brachytherapy of cervical cancer
Tanvir Pasha, Hanan Naniparuthayil Hassann, Nikhila Radhakrishna and 9 more
Journal of Contemporary Brachytherapy · 2021
doi:10.5114/jcb.2021.112113 (opens in a new tab)
We email you when a new notice or a question about this paper appears.
Abstract
Purpose: To evaluate feasibility and safety of execution of optimized intra-cavitary brachytherapy (ICBT) plan of first fraction in subsequent fractions in high-volume, low-resource centers. Material and methods:This non-randomized prospective study included 30 cervical cancer patients, who underwent 4 fractions of high-dose-rate (HDR)-ICBT in 2 applications, one week apart, 2 fractions per application delivered on two consecutive days.Computed tomography (CT) simulation was done before each fraction, organs at risk (OARs) were contoured on all sets of CT images.Optimized plans were generated for each set of CT images and executed for the treatment.Test treatment plans were retrospectively generated by applying first treatment fraction's dwell times adjusted for decay, and dwell positions of the applicator for subsequent treatment fractions paired t-test was performed to analyze D 2cc dose variations of OARs among the paired sets of plans.Results: Comparison between the plans showed daily plans provided lower D 2cc to OARs than test plans.In intraapplication plan comparison, there was a significant dose reduction to 2 cc sigmoid (p = 0.021) and bladder (p = 0.007) in daily plan.Mean D 2cc of optimized and unoptimized plans were 361.35 ±114.01 and 411.70 ±152.73 for sigmoid, and 511.23 ±85.47 cGy and 553.57±111.23 cGy for bladder, respectively.In inter-application, D 2cc rectum and sigmoid demonstrated a statistically significant dose variation (p = 0.002) and (p = 0.007), with mean D 2cc rectum of optimized and unoptimized plans being 401.06 ±83.53 cGy and 452.46 ±123.97 cGy, and of 2 cc sigmoid 340.84 ±117.90 cGy and 387.79 ±141.36 cGy, respectively.Conclusions: Fractionated HDR brachytherapy amounts to significant variation in OAR doses if re-simulation and re-plan is not performed for every fraction and ICBT application.Therefore, plan of the day with optimization of the doses to target and OARs must be followed for each fraction.
Abstract licence: CC BY-NC-SA
References23
23 more references, whose wording the paper’s licence keeps private.
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.